Effectiveness and safety of dupilumab in moderate‐to‐severe atopic dermatitis patients with chronic renal insufficiency: a real‐world retrospective study in China
Year: 2024
Type: article
Study design: Observational Study
Abstract: Effectiveness and safety of dupilumab in moderate-to-severe atopic dermatitis patients with chronic renal insufficiency: a real-
Source: MedComm
DOI: 10.1002/mco2.707
Authors: Cong Peng, Qiaozhi Cao, Feng Xiong, Hui Xu, Jie Li
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,500
Awards: G1048254890, G8021081879, G935794119
OpenAlex ID: W4402687540